Unknown

Dataset Information

0

Fabrication of water-soluble polymer-encapsulated As4S4 to increase oral bioavailability and chemotherapeutic efficacy in AML mice.


ABSTRACT: Realgar (As4S4) has been demonstrated to be effective for the treatment of acute myeloid leukemia (AML); it has the advantages of no drug resistance and oral administration. Nevertheless, its poor solubility has been an obstacle to its bioavailability, requiring high-dose administration over a long period. We investigated whether crushing realgar crystals to the nanoscale and encapsulating the particles in a water-soluble polymer in one step using hot-melt extrusion would increase the bioavailability of As4S4. Raw As4S4 (r-As4S4) and water-soluble polymer were processed via co-rotating twin screw extrusion. The resulting product (e-As4S4) was characterized by SEM, XRD, and DLS. The cytotoxicity and therapeutic effects of e-As4S4 were evaluated in vivo and in vitro. The results show that e-As4S4 dissolved rapidly in water, forming a stable colloid solution. The average size of e-As4S4 particles was 680 nm, which was reduced by more than 40-fold compared with that of r-As4S4. The bioavailability of e-As4S4 was up to 12.6-fold higher than that of r-As4S4, and it inhibited the proliferation of HL-60 cells much more effectively than did r-As4S4, inducing apoptosis and significantly reducing the infiltration of HL-60 cells into the bone marrow, spleen, and liver. This in turn prolonged the survival of AML mice.

SUBMITTER: Ma Q 

PROVIDER: S-EPMC4935940 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC5883060 | biostudies-literature
| S-EPMC9258130 | biostudies-literature
| S-EPMC4926210 | biostudies-literature
| S-EPMC8123473 | biostudies-literature
| S-EPMC5562699 | biostudies-other
| S-EPMC6645041 | biostudies-literature
| S-EPMC4346625 | biostudies-literature
| S-EPMC5566442 | biostudies-other
| S-EPMC4476993 | biostudies-literature
| S-EPMC5010604 | biostudies-literature